一个精确的机器学习模型:使用特征选择和可解释的AI检测子宫癌
Rashiduzzaman Shakil1, Sadia Islam1, Bonna Akter1
1Department of Computer Science and Engineering, Daffodil International University, Dhaka, Birulia 1216, Bangladesh.
Journal of pathology informatics
|November 4, 2024
概括
这项研究引入了机器学习模型,使用36个风险因素预测早期的宫癌. 决策树模型实现了高精度,改善了早期检测和患者护理.
科学领域:
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
- 人工智能的人工智能
背景情况:
- 宫癌是一个重大的全球卫生挑战,查差异加剧,导致死亡率增加.
- 早期检测和有效的管理对于改善患者的治疗结果和减少疾病负担至关重要.
研究的目的:
- 开发和评估用于早期预测宫癌的机器学习模型.
- 通过使用先进的计算技术,识别关键风险因素并增强诊断框架.
主要方法:
- 应用了6种机器学习模型 (决策树,物流回归,天真贝叶斯,随机森林,K-最近邻居,支持矢量机) 来分析858个人的36个风险因素.
- 数据不平衡是通过合成少数人过量采样技术 (SMOTE) 和自适应合成采样 (ADASYN) 来解决的.
- 使用奇平方和LASSO进行了特征选择,模型解释性通过Shapley添加式解释 (SHAP) 得到了增强.
主要成果:
- 决策树 (DT) 模型表现出卓越的性能,达到97.60%的准确性,98.73%的灵敏性,80%的特异性和98.73%的精度.
- 即使在数据不平衡的情况下,DT模型也保持了高性能,准确率为97%,灵敏度为99.35%,特异性为69.23%,精度为97.45%.
- 模型性能被严格评估,使用准确度,灵敏度,特异性,精度,F1得分,FPR,FNR和AUC等指标.
结论:
- 机器学习模型,特别是决策树,显示出用于准确预测早期宫癌的巨大潜力.
- 整合特征选择和可解释的AI提高了这些诊断工具的可靠性和临床适用性.
- 这项研究有助于开发用于改善宫癌检测,管理和个性化患者护理的自动诊断框架.
关键词:
这就是ADASYN.宫癌是发生在宫癌的原因之一.奇正方形的 奇正方形决策树 决策树是一个决策树.可解释的人工智能拉索·拉索 (Lasso) 是一个机器学习是机器学习.这就是 SHAP SHAP 的意思.在SMOTE中使用.更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.2K
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.5K
相关概念视频
01:15Receiver Operating Characteristic Plot
88
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
88
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328